The gut microbiome and metabolites are altered and interrelated in patients with functional constipation
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Introduction: Gut microbiota and metabolites have been identified to contribute to the pathogenesis of functional constipation (FC); however, the underlying mechanism(s) have not been elucidated, and the relationship between the gut microbiota and metabolites in FC has received limited attention in the literature. Methods: 16S rDNA sequencing and non-targeted metabolomic detection based on liquid chromatography-mass spectrometry (LC–MS/MS) technologies were combined to analyze the altered gut microbiome and metabolic profile of fecal samples from FC patients and healthy individuals (healthy control; HC). Results: The richness and diversity of gut microbiota significantly (p < 0.01) increased in FC patients. Compared to the HC group, 18 genera, including Intestinibacter, Klebsiella, and Akkermansia, exhibited statistically significant changes (p < 0.05). Metabolic analysis showed that metabolic profiles were also markedly altered with 79 metabolites, such as (-)-caryophyllene oxide, chenodeoxycholic acid, and biliverdin, indicating significant inter-group differences (p < 0.05). Besides, the primary bile acid biosynthesis, as well as the metabolic profile of porphyrin and chlorophyll, were the most dominant enriched pathways (FDR < 0.01), in which chenodeoxycholic acid and biliverdin were significantly enriched, respectively. Correlation analysis demonstrated a strong relationship between 10 genera and 19 metabolites (r > 0.6, FDR < 0.05), and notably, Intestinibacter showed a negative correlation with biliverdin (FDR < 0.001), which highlighted the interplay of the gut microbiota and metabolites in the pathogenesis of FC. Conclusion: Our research describes the characteristics of the gut microbiota and metabolic profiles and the correlation between the gut microbiota and metabolites in FC patients. This may contribute to the understanding of the underlying mechanisms involved in FC pathogenesis and may provide novel insights into therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with chronic constipation, there is evidence of intestinal dysbacteriosis, characterized by a decrease in the abundance of Bifidobacterium spp., Lactobacillus spp., Prevotella spp., and butyrate-producing genera [10], but an increase in the abundance of Coprococcus, Ruminococcus spp., Akkermansia, and Clostridium spp.[11,12].”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [12]
In the citing paper
“BAs possess the ability to regulate intestinal motility, secretion, and absorption as well as to prevent excessive proliferation of gut microbes, thereby maintaining the integrity of the intestinal mucosal barrier [12].”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Mukherjee, A., Lordan, C., Ross, R. P., & Cotter, P. D. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1802866 · Cited by 690
Chronic constipation: a survey of the patient perspective
JOHANSON, J. F., & KRALSTEIN, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03238.x · Cited by 617
Forbes, J. D., Chen, C.-Y., Knox, N. C., Marrie, R.-A., El-Gabalawy, H., de Kievit, T., Alfa, M., Bernstein, C. N., & Van Domselaar, G. (2018) · Microbiome · doi:10.1186/s40168-018-0603-4 · Cited by 450
Barberio, B., Judge, C., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00111-4 · Cited by 422
Park, K.-R., Nam, D., Yun, H.-M., Lee, S.-G., Jang, H.-J., Sethi, G., Cho, S. K., & Ahn, K. S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.001 · Cited by 331
Constipation and risk of death and cardiovascular events
Sumida, K., Molnar, M. Z., Potukuchi, P. K., Thomas, F., Lu, J. L., Yamagata, K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.021 · Cited by 287
Cao, H., Liu, X., An, Y., Zhou, G., Liu, Y., Xu, M., Dong, W., Wang, S., Yan, F., Jiang, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10835-8 · Cited by 253
Self-citation
Cited by
Scanu, M., Toto, F., Petito, V., Masi, L., Fidaleo, M., Puca, P., Baldelli, V., Reddel, S., Vernocchi, P., Pani, G., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1366192 · Cited by 45
Wang, K., Qiu, H., Chen, F., Cai, P., & Qi, F. (2024) · BioScience Trends · doi:10.5582/bst.2024.01036 · Cited by 34
Chronic constipation and gut microbiota: current research insights and therapeutic implications
Xu, X., Wang, Y., Long, Y., & Cheng, Y. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae112 · Cited by 32
Hu, L., Liu, Q., Ke, X., Zhao, P., Fang, W., & Ren, Y. X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1591697 · Cited by 19
Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity
Wang, J., He, J., Liu, D., Zhang, T., Wu, Y., & Xie, M. (2024) · Microbiology and Immunology · doi:10.1111/1348-0421.13187 · Cited by 11
Metadata
- Authors
- Li, Y.-Q., Yan, X.-Y., Xiao, X.-J., Ma, P.-T., Wang, S.-Q., Liu, H.-L., Zhang, W., Chen, M., Yao, J.-P., & Li, Y.
- Affiliations
- Chengdu University of Traditional Chinese Medicine (CN)
- Corresponding author
- Li, Ying
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2023-12-06
- Volume
- 14
- Pages
- 1320567-1320567
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC10731029
- OpenAlex
- W4389393171
- Cited by
- 22
- References
- 48
- Citations by year
- 2026: 11 · 2025: 4 · 2024: 7
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82074554)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- functional constipation, gut microbiota, fecal metabolites, biliverdin, fecal microbiota, metabolite profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The gut microbiome and metabolites are altered and interrelated in patients with functional constipation. https://app.cochat.ai/papers/10.3389/fmicb.2023.1320567
- The paper
- Li, Y.-Q., Yan, X.-Y., Xiao, X.-J., Ma, P.-T., Wang, S.-Q., Liu, H.-L., Zhang, W., Chen, M., Yao, J.-P., & Li, Y. (2023). The gut microbiome and metabolites are altered and interrelated in patients with functional constipation. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2023.1320567
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.